PRECISION BIOSCIENCES INC Earnings Per Share Disclosure
| Years Ended December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| (Loss) income from continuing operations (in thousands) | $ | (46,609) | $ | 7,167 | |||||||
| Gain (loss) from discontinued operations (in thousands) | 885 | — | |||||||||
| Net (loss) income (in thousands) | $ | (45,724) | $ | 7,167 | |||||||
| Basic weighted-average common shares | 12,826,078 | 6,832,982 | |||||||||
| Dilutive impact of share-based awards | — | 50,929 | |||||||||
| Diluted weighted-average common shares (1) | 12,826,078 | 6,883,911 | |||||||||
| Basic net (loss) income per share: | |||||||||||
| Basic (loss) income from continuing operations | (3.63) | 1.05 | |||||||||
| Basic gain (loss) from discontinued operations | 0.07 | — | |||||||||
| Basic net (loss) income per share | (3.56) | 1.05 | |||||||||
| Diluted net (loss) income per share: | |||||||||||
| Diluted (loss) income from continuing operations | (3.63) | 1.04 | |||||||||
| Diluted gain (loss) from discontinued operations | 0.07 | — | |||||||||
| Diluted net (loss) income per share | (3.56) | 1.04 | |||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 12, 2026 | Showing above |
| 2024 | Mar 26, 2025 | |
| 2023 | Mar 27, 2024 | |
| 2022 | Mar 9, 2023 | |
| 2021 | Mar 15, 2022 | |
| 2020 | Mar 18, 2021 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.